研究者情報   
   検索ページ


    (最終更新日:2018-06-16 17:03:44)
  スナカワ ユウ   SUNAKAWA YU
  砂川 優
   所属   医学部医学科 臨床腫瘍学
   職種   准教授
■ 学術雑誌
1. 原著  CEA response and depth of response (DpR) to predict clinical outcomes of first-line cetuximab treatment for metastatic colorectal cancer 2017/12
2. 原著  Early morphological change for predicting outcome in metastatic
colorectal cancer after regorafenib 2017/12
3. 総説  Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy 2017/09
4. 総説  抗EFGR抗体薬を使うべき症例、ひとまず様子をみるべき症例 2017/08
5. 総説  大腸がんに対する臨床開発と方向性 2017/07
全件表示(6件)
■ 学会発表
1. Phase I study of the anti-heparin binding-EGF antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer (ポスター) 2018/04
2. Association of genetic variations within the PD-L2 immune checkpoint gene with outcome in stage II and III colon cancer.  2018/01
3. Initial therapy with FOLFOXIRI plus bevacizumab (bev) for RAS mutant metastatic colorectal cancer (mCRC) and gene mutations in circulating tumor DNA (ctDNA) as a predictive marker for the efficacy: JACCRO CC-11.  2018/01
4. The nationwide screening project on plasma angiogenesis-related mediators for treatment selection of optimal antiangiogenic inhibitors in metastatic colorectal cancer: GI-SCREEN CRC-Ukit.  2018/01
5. Dynamic changes in levels of gene mutations using circulating DNA and efficacy of 1st-line modified FOLFOXIRI plus bevacizumab for metastatic colorectal cancer harboring RAS mutation (JACCRO CC-11)  2017/09/08
全件表示(9件)